AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)

CUSIP: 00847X104

Q1 2026 13F Holders as of 31 Mar 2026

Security identity
Security type / class
Equity / Common Stock, Par Value $0.001 per share
Shares outstanding
59,431,072
Holder snapshot
Total 13F shares
63,038,208
Share change
+1,590,239
Total reported value
$2,119,469,955
Put/Call ratio
11%
Reported price per share
$33.83
Number of holders
230
Value change
+$71,916,598
Number of buys
109
Number of sells
117

Security key

00847X104

Report period

Q1 2026

Institutions

230

Top holders

10

AGIO full security history Ownership snapshot Full 13F holder table Previous quarter: Q4 2025 AGIOS PHARMACEUTICALS, INC. SEC filings AGIOS PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Farallon Capital Partners...
13D/G signal
Farallon Capital Partners...
Evidence rows
15
Latest as of
31 Mar 2026
13D/G 13F Lead comparable stake: 8.8% 13D/G row: Farallon Capital Partners, L.P. Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Farallon Capital Partners, L.P.
13D/G
Dapice Joshua J.
13D/G
8.8%
$146,117,182
5,159,505 shares
 -$14,583,696 31 Dec 2025
BlackRock, Inc.
13D/G 13F
Company
13D/G 13F
7.8%
$150,100,362
4,513,170 shares
 $0 30 Jun 2025
STATE STREET CORP
13D/G 13F
STATE STREET CORPORATION · Company
13D/G 13F
5.3%
$88,022,666
3,108,145 shares
 $0 31 Dec 2025
VANGUARD CAPITAL MANAGEMENT LLC
13D/G
Vanguard Capital Management
13D/G
5.3%
$104,472,757
3,088,169 shares
 $0 31 Mar 2026
Paradigm Biocapital Advisors LP
13D/G
13D/G
4.9%
$115,344,498
2,873,555 shares
 -$6,198,499 30 Sep 2025
ARMISTICE CAPITAL, LLC
13D/G 13F
Company
13D/G 13F
4.6%
$95,358,760
2,716,000 shares
 -$11,235,200 31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
230
Shares
63,038,208
Rows available
230
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
237
Q1 2026 holders
230
Holder diff
-7
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .